BENJAMIN LI to Combined Modality Therapy
This is a "connection" page, showing publications BENJAMIN LI has written about Combined Modality Therapy.
Connection Strength
0.060
-
Neoadjuvant chemotherapy in stage III breast cancer. Am Surg. 2005 Jun; 71(6):487-92.
Score: 0.046
-
Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). Breast Cancer Res Treat. 2009 Jan; 113(2):293-9.
Score: 0.014